Navigation Links
Maxygen Reports Fourth Quarter and Year End 2007 Financial Results
Date:2/12/2008

pany's lead program, MAXY-G34, is designed to be an improved version of PEG-GCSF for the treatment of neutropenia. MAXY-G34 is currently in Phase II clinical trials. Also in Maxygen's pipeline is a new Factor VIIa product candidate for the treatment of hemophilia and new CTLA4-Ig product candidates for the treatment of rheumatoid arthritis. Maxygen uses its proprietary DNA shuffling technology and extensive protein modification expertise to pursue the creation of biosuperior proteins. http://www.maxygen.com

Forward-Looking Statements

This news release contains forward-looking statements about our research and business prospects, including those relating to our ability to develop any human therapeutic products suitable for commercialization; our ability or plans to commence or continue the preclinical or clinical development of any of our product candidates, including MAXY-G34 and MAXY-VII, and the timing and status of any such development; the status of the consolidation of our operations and the impact of such consolidation on our cash utilization and financial position; and our liquidity and future financial performance, including the adequacy of our current cash resources and other assets to fund our future operations and/or for future capital requirements. Such statements involve risks and uncertainties that may cause results to differ materially from those set forth in these statements. Among other things these risks and uncertainties include, but are not limited to, changing research and business priorities, the inherent uncertainties of pharmaceutical research and drug development, our ability to develop human therapeutic drugs in an increasingly competitive biotechnology industry and the uncertain timing of such development, the development of superior products by competitors, and our ability to establish and maintain our research and commercialization collaborations and manufacturing arrangeme
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Maxygen to Present at the Roth 20th Annual OC Growth Stock Conference
2. Maxygen to Present at the Stanford Group Company 13th Annual Healthcare Conference
3. Maxygen to Present at the JPMorgan 26th Annual Healthcare Conference
4. Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
5. Maxygen Reports Third Quarter 2007 Financial Results
6. Maxygen Announces Upcoming Webcasts at Investor Conferences
7. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
8. Maxygen Announces Hold on MAXY-alpha Development Program
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers
11. Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... 2, 2015 Cutting-edge biotech ... food nutrition products reveal technological advancements are in ... such as hyperglycemia, obesity, insulin level issues and ... Biotech Companies in focus today are: RiceBran Technologies (NASDAQ: ... (NYSE: ANFI ), CEL-SCI Corporation (NYSE: ...
(Date:3/2/2015)... 02, 2015 Global Stem ... alliance with Shenzhen HANK Bioengineering Co., Ltd. and ... alliance will establish a stem cells training course ... in September 2015. , Shenzhen HANK is a ... award-winning scientist, microbiologist and virologist, to integrate research, ...
(Date:2/27/2015)... and SUMMERLAND, British Columbia , ... XON ), a leader in synthetic biology, ... acquire  Okanagan Specialty Fruits (OSF), the pioneering agricultural ... the world,s first non-browning apple. Through the acquisition, Intrexon ... that is more appetizing and convenient for consumers while ...
(Date:2/27/2015)... The fully automated supercritical fluidic chromatography-based ... analyze up to 48 samples utilizing automatic extraction ... targets by mass spectrometry. , The Nexera ... requirements of a wide range of applications, including ... search for disease biomarkers, additives in forming polymers, ...
Breaking Biology Technology:Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 2Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 3Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 4Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 5Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 6Clinical Studies & Research Substantiate Claims That Company's Targeted Healthy Nutritional Products Promote Healthy Lipids, Glucose & Insulin Levels 7Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Intrexon to Acquire Okanagan Specialty Fruits 2Intrexon to Acquire Okanagan Specialty Fruits 3Intrexon to Acquire Okanagan Specialty Fruits 4Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 2Shimadzu Corporation Launches Nexera UC - The World’s Foremost Unified Chromatography System 3
... SHORT HILLS, N.J., Jan. 23 Peter T. Wilderotter, ... Foundation, issued the following statement today in response to ... stem cell-based therapy:"This is an exciting first step for ... may improve due to advances in medical research. There ...
... Jan. 22 ScienceFirst is pleased to ... the Cedar Knolls office.(Photo: http://www.newscom.com/cgi-bin/prnh/20090122/NY61733-a ... Sudakin, PhD, has been named science manager. ... investigator at GlaxoSmithKline, where he co-lead the ...
... Hutchinson Cancer Research Center,s,stem-cell transplant program at the ... two transplant programs nationwide that consistently outperformed,the expected ... an independent report that assessed 122 transplant centers ... The Center for International Blood and Marrow Transplant ...
Cached Biology Technology:Christopher and Dana Reeve Foundation Response to FDA Clearance of Geron's Clinical Trial 2ScienceFirst Staff Expansion 2Transplant Program Tops in Expected One-Year Survival Rate 2
(Date:2/12/2015)... , Feb. 12, 2015   MedNet Solutions ... in clinical study management systems, has recently bolstered ... further distinguishing iMedNet as ... Organizations (CROs) and healthcare consultants.  Building on the ... customer referrals and numerous co-marketing opportunities), MedNet,s new ...
(Date:2/5/2015)... Carolina , 5. Februar 2015 /PRNewswire/ ... als spezialisiertes Logistikunternehmen und hat eine neue ... klinische Logistikfirma (Clinical Logistics Organization – CLO) ... neuen Kampagne lautet First , mit ... Foto: http://photos.prnewswire.com/prnh/20150205/173753 ...
(Date:2/5/2015)... January 28, 2015 New Market ... And Segment Forecasts To 2020 has Been Added to ... market is expected to reach USD 5.10 billion by ... Research, Inc. IR cameras help identify the site of ... to witness surging demand in medical imaging applications. They ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Marken startet Kampagne mit Patienten im Mittelpunkt 2Marken startet Kampagne mit Patienten im Mittelpunkt 3IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3
... expand and generate a lot of smoke visible on NASA ... blowing the smoke to the north-northeast and into Wyoming and ... Fire is located approximately 15 miles west of Fort Collins, ... homes have been lost, according to the U.S. Forest Service. ...
... teenagers and young women, but a new study reveals that age ... over, 3.5% report binge eating, nearly 8% report purging, and more ... the International Journal of Eating Disorders revealed that 62% ... their life. The researchers, led by Dr Cynthia Bulik, Director ...
... research shows that omega-3 fatty acid supplements can lower ... suggesting that regular use of these supplements could help ... of omega-3 supplementation decreased one protein in the blood ... of more than 10 percent, and led to a ...
Cached Biology News:Eating disorder behaviors and weight concerns are common in women over 50 2Omega-3 lowers inflammation in overweight older adults 2Omega-3 lowers inflammation in overweight older adults 3Omega-3 lowers inflammation in overweight older adults 4
This thermal printer, 120 V, provides a permanent record of the preprogrammed method and run data for the PROTEAN IEF cell. Includes cable and power adaptor....
... this kit to purify genomic DNA from plants in ... beating in a deep well plate using large zirconia ... a high velocity plate shaker (available through Mo Bio). ... silica membrane spin filter plate. The DNA is washed ...
... thermal cycler with 384-well reaction module is ... It is equipped with an interchangeable, 384-well ... algorithm temperature monitoring and control and ramp ... volumes. It includes the iCycler base with ...
... array systems, known as ChemiArrayTM Mouse ... compared with current methodologies. Besides the ... systems present a more accurate reflection ... only detect secreted cytokines, and no ...
Biology Products: